Duopharma Biotech Bhd (DUOP)

Kuala Lumpur
Currency in MYR
1.230
+0.010(+0.82%)
Closed
DUOP Scorecard
Full Analysis
High shareholder yield
Fair Value
Day's Range
1.2201.240
52 wk Range
1.1001.450
Key Statistics
Edit
Bid/Ask
1.22 / 1.24
Prev. Close
1.23
Open
1.22
Day's Range
1.22-1.24
52 wk Range
1.1-1.45
Volume
50.4K
Average Volume (3m)
460.86K
1-Year Change
-3.17%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
DUOP Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
1.475
Upside
+19.92%
Members' Sentiments
Bearish
Bullish
ProTips
Stock generally trades with low price volatility
Show more

Duopharma Biotech Bhd Company Profile

Duopharma Biotech Berhad, an investment holding company, researches, develops, manufactures, distributes, and imports pharmaceutical products and medicines in Malaysia and internationally. The company offers consumer healthcare products comprising vitamins and supplements, analgesics, eyecare, antacids, and skin care products; and generic drugs for various therapeutic classes, such as cardiovascular, dermatology, hormones, respiratory, sensory and nervous system, musculo-skeletal system, anti-infectives, and others. It also provides specialty pharmaceutical drugs for targeted conditions, biosimilar products, and medical devices and consumables to patients with conditions, such as diabetes, cancer, cardiovascular diseases, renal diseases, and others. The company’s product portfolio comprises vascor, acetan, covasc, crystorvas, bezartan, vytan, and vytocor; insugen and basalog one; kytron, zuhera, lebreta, trevive, and krabeva; and unihepa, ranofer, erysaa, bi-haemosol, and haemosol. The company offers its products under the Champs, Flavettes, Eye Glo, Proviton, Naturalle, and Uphamol brands. In addition, it offers property management and services; and distributes, imports, and exports chemical products. The company was formerly known as CCM Duopharma Biotech Berhad and changed its name to Duopharma Biotech Berhad in February 2019. Duopharma Biotech Berhad was founded in 1978 and is headquartered in Kuala Lumpur, Malaysia.

Employees
1650
Market
Malaysia

Compare DUOP to Peers and Sector

Metrics to compare
DUOP
Peers
Sector
Relationship
P/E Ratio
20.9x19.2x−0.6x
PEG Ratio
−2.30−0.130.00
Price/Book
1.7x2.2x2.6x
Price / LTM Sales
1.5x3.0x3.1x
Upside (Analyst Target)
19.5%31.5%51.7%
Fair Value Upside
Unlock8.7%7.5%Unlock

Analyst Ratings

3 Buy
1 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 1.475
(+19.92% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.058
Dividend Yield
2.30%
Industry Median 3.25%
Annualised payout
0.0280
Paid unevenly
5-Years Growth
-5.68%
Growth Streak

Earnings

Latest Release
Nov 08, 2024
EPS / Forecast
0.016 / --
Revenue / Forecast
208.70M / 208.70M
EPS Revisions
Last 90 days

FAQ

What Is the Duopharma Biotech (DUOP) Stock Price Today?

The Duopharma Biotech stock price today is 1.23

What Stock Exchange Does Duopharma Biotech Trade On?

Duopharma Biotech is listed and trades on the Kuala Lumpur stock exchange.

What Is the Stock Symbol for Duopharma Biotech?

The stock symbol for Duopharma Biotech is "DUOP."

Does Duopharma Biotech Pay Dividends? What’s The Current Dividend Yield?

The Duopharma Biotech dividend yield is 2.28%.

What Is the Duopharma Biotech Market Cap?

As of today, Duopharma Biotech market cap is 1.18B.

What is Duopharma Biotech Earnings Per Share?

The Duopharma Biotech EPS is 0.058.

What Is the Next Duopharma Biotech Earnings Date?

Duopharma Biotech will release its next earnings report on 23 Feb 2025.

From a Technical Analysis Perspective, Is DUOP a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.